title: Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia.
abstract: Here, we present a case of chronic myeloid leukemia for which imatinib therapy was initated. Triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone was normal, and thyroid microsomal autoantibodies (TMA) were positive and patient was diagnosed as thyroiditis treated with corticosteroids for 1½ months which lead to resolution.
authors.affiliation: Department of Pharmacology, AIIMS, Jodhpur, Rajasthan, India.
authors.forename: Surjit
authors.initials: S
authors.lastname: Singh
authors.affiliation: Department of Pharmacology, AIIMS, Jodhpur, Rajasthan, India.
authors.forename: Pramod Kumar
authors.initials: PK
authors.lastname: Sharma
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D013967:Thyroiditis, Autoimmune / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate
keywords: Chronic myeloid leukemia; imatinib; thyroiditis